Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Allan Shaw

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Health Estate|March 11, 2003
Delivering shared support servicesAllan Shaw
Communication & Medicine|August 24, 2007
The construction of identity during group therapy among adults with traumatic brain injuryDana Kovarsky, Allan Shaw, Maureen Adingono-Smith
Frontiers in Cellular Neuroscience|February 27, 2026
C9orf72-ALS mutation drives basal mitophagy impairments in iNeuronsJames A K Lee, Chloe Moutin, Sarah Granger, et al.
Molecular Psychiatry|September 13, 2024
Increasing hexokinase 1 expression improves mitochondrial and glycolytic functional deficits seen in sporadic Alzheimer's disease astrocytesSimon M Bell, Hollie Wareing, Francesco Capriglia, et al.
Medrxiv : the Preprint Server for Health Sciences|April 18, 2024
Deep learning modeling of rare noncoding genetic variants in human motor neurons defines <i>CCDC146</i> as a therapeutic target for ALSSai Zhang, Tobias Moll, Jasper Rubin-Sigler, et al.
Molecular Neurodegeneration|November 4, 2025
M102 activates both NRF2 and HSF1 transcription factor pathways and is neuroprotective in cell and animal models of amyotrophic lateral sclerosisAmy F Keerie, Raquel Rua Martins, Chloe F Allen, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Health Estate|March 11, 2003
Delivering shared support servicesAllan Shaw
Communication & Medicine|August 24, 2007
The construction of identity during group therapy among adults with traumatic brain injuryDana Kovarsky, Allan Shaw, Maureen Adingono-Smith
Frontiers in Cellular Neuroscience|February 27, 2026
C9orf72-ALS mutation drives basal mitophagy impairments in iNeuronsJames A K Lee, Chloe Moutin, Sarah Granger, et al.
Molecular Psychiatry|September 13, 2024
Increasing hexokinase 1 expression improves mitochondrial and glycolytic functional deficits seen in sporadic Alzheimer's disease astrocytesSimon M Bell, Hollie Wareing, Francesco Capriglia, et al.
Medrxiv : the Preprint Server for Health Sciences|April 18, 2024
Deep learning modeling of rare noncoding genetic variants in human motor neurons defines <i>CCDC146</i> as a therapeutic target for ALSSai Zhang, Tobias Moll, Jasper Rubin-Sigler, et al.
Molecular Neurodegeneration|November 4, 2025
M102 activates both NRF2 and HSF1 transcription factor pathways and is neuroprotective in cell and animal models of amyotrophic lateral sclerosisAmy F Keerie, Raquel Rua Martins, Chloe F Allen, et al.
Pageof 1